NeuroMetrix Inc. announced that it has appointed Frank McGillin as Senior Vice President and General Manager, Consumer. Mr. McGillin will be responsible for development of a consumer healthcare business built on the company's wearable therapeutic technology for treatment of chronic pain which was recently cleared by the FDA for over-the-counter use without a prescription requirement. Mr. McGillin brings to the company over 20 years experience building successful, high-growth consumer brands most recently at Philips Oral Healthcare and at Johnson & Johnson.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.84 USD | +0.52% | -8.35% | +6.67% |
04-19 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
04-19 | Sector Update: Health Care Stocks Rise Friday Afternoon | MT |
1st Jan change | Capi. | |
---|---|---|
+6.67% | 7.63M | |
-4.77% | 182B | |
+4.10% | 114B | |
-3.85% | 67.76B | |
+5.19% | 51.91B | |
+5.54% | 43.23B | |
+6.07% | 41.07B | |
+23.81% | 32.07B | |
+15.86% | 25B | |
-5.06% | 24.35B |
- Stock Market
- Equities
- NURO Stock
- News NeuroMetrix, Inc.
- NeuroMetrix Appoints Frank McGillin as Senior Vice President and General Manager, Consumer